Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VEGFR2/CD309 antibody (N-Term)

The Rabbit Polyclonal anti-VEGFR2/CD309 antibody has been validated for WB and IHC. It is suitable to detect VEGFR2/CD309 in samples from Human, Pig, Dog, Cow and Horse.
Catalog No. ABIN2792307

Quick Overview for VEGFR2/CD309 antibody (N-Term) (ABIN2792307)

Target

See all VEGFR2/CD309 (VEGFR2) Antibodies
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivity

  • 323
  • 204
  • 145
  • 17
  • 10
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Pig, Dog, Cow, Horse

Host

  • 299
  • 67
  • 27
  • 4
  • 1
  • 1
  • 1
  • 1
Rabbit

Clonality

  • 290
  • 111
Polyclonal

Conjugate

  • 185
  • 35
  • 21
  • 12
  • 11
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
This VEGFR2/CD309 antibody is un-conjugated

Application

  • 231
  • 127
  • 119
  • 109
  • 66
  • 42
  • 40
  • 26
  • 26
  • 16
  • 13
  • 13
  • 9
  • 7
  • 7
  • 7
  • 3
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Binding Specificity

    • 37
    • 34
    • 27
    • 23
    • 20
    • 16
    • 16
    • 13
    • 13
    • 11
    • 10
    • 8
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Sequence

    LNVGIDFNWE YPSSKHQHKK LVNRDLKTQS GSEMKKFLST LTIDGVTRSD

    Predicted Reactivity

    Cow: 86%, Dog: 100%, Horse: 100%, Human: 100%, Pig: 100%

    Characteristics

    This is a rabbit polyclonal antibody against KDR. It was validated on Western Blot using a cell lysate as a positive control.

    Purification

    Affinity Purified

    Immunogen

    The immunogen is a synthetic peptide directed towards the N terminal region of human KDR
  • Application Notes

    Optimal working dilutions should be determined experimentally by the investigator.

    Comment

    Antigen size: 1356 AA

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Target

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Alternative Name

    KDR

    Background

    KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
    Alias Symbols: CD309, FLK1, VEGFR, VEGFR2
    Protein Interaction Partner: FBXO25, VEGFA, MYO1C, CAV1, NPM1, EPN1, SRC, CBL, IQGAP1, UBC, CSNK1D, FBXW11, BTRC, CUL1, AIMP2, SHC2, SYNGAP1, ACP1, ATR, FRS2, SH2D2A, DNM2, NRP1, VEGFC, GRB10, CDH5, GNAQ, SHC1, STAT1, NCK1, SHB, PLCG2, P2RY2, BMX, FIGF, KDR, TIMP3, PTPN6, PTPN11, ITG
    Protein Size: 1356

    Molecular Weight

    151 kDa

    Gene ID

    3791

    NCBI Accession

    NM_002253, NP_002244

    UniProt

    P35968

    Pathways

    RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
You are here:
Chat with us!